Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

Novel Coronavirus (COVID-19) : Coronavirus : The explosive rise in cases of coronavirus infection is of concern worldwide. Stay up-to-date here.

The findings could have sweeping implications for drug developers already working to design antivirals based on flawed assumptions, and underscore the importance of rigorous validation.

Moderna said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot for the virus in a late-stage trial. The positive data pave the way for Moderna ...

Thus, it may be not applicable in COVID-19 because the COVID-19 is a contagious disease and relatively irrelevant to a genetic disorder. Up to date, there is still a lack of clinical and laboratory ...